Chlamydia is a sexually transmitted infection, caused by the bacteria chlamydia trachomatis. It is thought to be the most common STI in the UK, with around 200,000 infections reported at GUM clinics and surgeries each year. It more commonly affects young people, between the ages of 18 and 24. Women tend to be more susceptible to the condition than men, but less likely to develop noticeable symptoms during the initial stages of infection. While as many as 50% of men who carry the infection may show no visible signs, a staggering 80% of women may display no indications of the disease either, making it very easy to remain undetected. In other cases where symptoms are present, a woman with chlamydia may experience urinary pain, increased menstrual bleeding, or vaginal discharge; whereas a man might notice instances of penile discharge, urinary pain, or testicular pain. However, the condition can still be harmful even in cases where it does not cause symptoms. As part of our continuous efforts to enhance Internet experience for our customers, we have upgraded our Domain Name System (DNS). This upgrading exercise will affect the DNS Internet Protocol (IP) address 220.127.116.11 where the IP address will be decommissioned in stages starting January 2018.
Azithromycin is to be made available over the counter to treat asymptomatic chlamydia infection, the Medicines and Healthcare products Regulatory Agency announced today (6 August 2008). It is the first oral antibiotic to be switched from prescription-only to pharmacy medicine status. The drug will be available as Clamelle for people over 16 years of age who have tested positive for chlamydia but have no symptoms, and for their sexual partners. June Raine, director of vigilance and risk management of medicines at the MHRA, said: “The MHRA is keen to support the availability of more medicines over the counter where it is safe to do so, and we wish to move on to new areas, such as prevention and chronic disease management. We know many pharmacists are ready for this too.“Making this medicine available from a pharmacy is a real example of how we are progressing, and enabling people to play an active role in taking charge of their own healthcare.”Howard Duff, the Royal Pharmaceutical Society’s director for England, said that the decision would mean convenient and effective care for patients. “Pharmacists already play an important role in the provision of sexual health services, and have done so for many years. Reclassifying azithromycin will expand on existing services and improve access to chlamydia screening and treatment for patients.”The fpa also welcomed the decision. Azithromycin is no longer recommended for treating chlamydia. This is because it no longer works well as a treatment, due to an increase in antibiotic resistance. This change in treatment recommendations comes from national guidelines published by BASHH. The current recommended treatment for chlamydia is now doxycycline. Azithromycin is an antibiotic which is used to treat a range of bacterial infections. These bacteria need certain proteins, without which they can’t grow and reproduce. Azithromycin prevents the bacteria from producing the proteins, thus preventing them from multiplying.
Azithromycin is to be made available over the counter to treat asymptomatic chlamydia infection, the Medicines and Healthcare products Regulatory Agency announced today 6 August 2008. It is the first oral antibiotic to be switched from prescription-only to pharmacy medicine. No Prescription Needed Canada Buy Zithromax Online Discount Azithromycin Pills Azithromycin Lowest Prices Azithromycin Sales Usa Suprax Shipped From.